Literature DB >> 16631136

Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration.

Deepinder Kaur1, Subramanian Rajagopalan, Shankar Chinta, Jyothi Kumar, Donato Di Monte, Robert A Cherny, Julie K Andersen.   

Abstract

Ferritin elevation has been reported by some laboratories to occur within the substantia nigra (SN), the area of the brain affected in Parkinson's disease (PD), but whether such an increase could be causatively involved in neurodegeneration associated with the disorder is unknown. Here, we report that chronic ferritin elevation in midbrain dopamine-containing neurons results in a progressive age-related neurodegeneration of these cells. This provides strong evidence that chronic ferritin overload could be directly involved in age-related neurodegeneration such as occurs in Parkinson's and other related diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16631136     DOI: 10.1016/j.brainres.2006.03.006

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  25 in total

1.  Hemoglobin and iron handling in brain after subarachnoid hemorrhage and the effect of deferoxamine on early brain injury.

Authors:  Jin-Yul Lee; Richard F Keep; Yangdong He; Oren Sagher; Ya Hua; Guohua Xi
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-25       Impact factor: 6.200

2.  Ferritin as a reporter gene for MRI: chronic liver over expression of H-ferritin during dietary iron supplementation and aging.

Authors:  Keren Ziv; Gila Meir; Alon Harmelin; Eyal Shimoni; Eugenia Klein; Michal Neeman
Journal:  NMR Biomed       Date:  2010-06       Impact factor: 4.044

Review 3.  Genetic engineered molecular imaging probes for applications in cell therapy: emphasis on MRI approach.

Authors:  In K Cho; Silun Wang; Hui Mao; Anthony Ws Chan
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-09-22

Review 4.  Cell-based therapies for Huntington's disease.

Authors:  Yiju Chen; Richard L Carter; In K Cho; Anthony W S Chan
Journal:  Drug Discov Today       Date:  2014-03-12       Impact factor: 7.851

5.  Brain iron metabolism and brain injury following subarachnoid hemorrhage: iCeFISH-pilot (CSF iron in SAH).

Authors:  Joao A Gomes; Magdy Selim; Anne Cotleur; M Shazam Hussain; Gabor Toth; Lauren Koffman; Khaled Asi; J Javier Provencio
Journal:  Neurocrit Care       Date:  2014-10       Impact factor: 3.210

Review 6.  Mitochondrial iron metabolism and its role in neurodegeneration.

Authors:  Maxx P Horowitz; J Timothy Greenamyre
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

7.  Noninvasive monitoring of embryonic stem cells in vivo with MRI transgene reporter.

Authors:  Jun Liu; Eric C H Cheng; Robert C Long; Shang-Hsun Yang; Liya Wang; Pei-Hsun Cheng; Jinjing Yang; Dong Wu; Hui Mao; Anthony W S Chan
Journal:  Tissue Eng Part C Methods       Date:  2009-12       Impact factor: 3.056

8.  Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease.

Authors:  Deepinder Kaur; Subramanian Rajagopalan; Julie K Andersen
Journal:  Brain Res       Date:  2009-08-21       Impact factor: 3.252

9.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

10.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.